Jyotismita Thakuria¹*, Rajendragouda Patil² and Udita Singh³

¹Post Graduation Student, Oral Medicine and Radiology, Kothiwal Dental College and Research Centre, Moradabad, India
²Professor and Head, Oral medicine and Radiology, Kothiwal Dental College and Research Centre, Moradabad, India
³Reader, Oral Medicine and Radiology, Kothiwal Dental College and Research Centre, Moradabad, India

*Corresponding Author: Jyotismita Thakuria, Post Graduation Student, Oral Medicine and Radiology, Kothiwal Dental College and Research Centre, Moradabad, India

Received: August 30, 2021; Published: September 25, 2021

Abstract

  Though there have been an outbreak of mucormycosis infection in covid-19 patients, it was prevalent even before the pandemic. When the defense system of the human body is damaged or the concentration of pathogens reach an exceptionally high density, opportunistic infection such as mucormycosis may emerge. Mucormycosis is the most deadly and rapidly progressive form of fungal infection caused by a saprophytic fungus, mainly Rhizopus or Mucor. Mucorales gain entry to the susceptible host from the environment through skin contact with or without trauma, or via inhalation or ingestion of fungal spores. These routes result in rhino-orbito-cerebral, pulmonary, gastrointestinal, or cutaneous/wound infections. Here we present a case of 42 year old diabetic patient who was diagnosed with mucormycosis causing extensive maxillary and alveolar necrosis before the Covid-19 pandemic.

Keywords: Fungal; Infection; Opportunistic; Mucormycosis; Necrosis; Black Fungus

References

1. Lehrer RI., et al. “Mucormycosis”. Annals of Internal Medicine 93 (1980): 93-108.
2. Nilesh K and Vande AV. “Mucormycosis of maxilla following tooth extraction in immunocompetent patients: Reports and review”. Journal of Clinical and Experimental Dentistry 3 (2018): e300-305.
3. Hosseini SM and Borghei P. “Rhinocerebral mucormycosis: pathways of spread”. European Archives of Oto-Rhino-Laryngology 262 (2005): 932-938.
4. Roden MM., et al. “Epidemiology and outcome of zygomycosis: a review of 929 reported cases”. Clinical Infectious Diseases5 (2005): 634-653.
5. Kim J., et al. “A Fatal Outcome From Rhinocerebral Mucormycosis After Dental Extractions: A Case Report”. Journal of Oral and Maxillofacial Surgery 59 (2001): 693-697.
6. Jones AC., et al. “Mucormycosis of the oral cavity”. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 75 (1993): 455-460.
7. Cornely OA., et al. “ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013”. Clinical Microbiology and Infection 3 (2014): 5-26.

Citation

Citation: Jyotismita Thakuria., et al. “Mucormycosis in a Diabetic Patient”. Acta Scientific Dental Sciences 5.10 (2021): 80-83.

Copyright

Copyright: © 2021 Jyotismita Thakuria., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.